Lisata Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
/ 
Frequently asked questions
To buy Lisata Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lisata Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lisata Therapeutics Inc. is LSTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lisata Therapeutics Inc. has its primary listing on NASDAQ. You can trade Lisata Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lisata Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lisata Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lisata Therapeutics Inc..